Clear evidence of Revita activity: The study met its 3-month efficacy endpoint with strong statistical significance (p=0.014), delivering 2.5% further weight loss with Revita (n=29) even after stopping tirzepatide, versus 10% weight regain in sham-treated patients (n=16)
Zhang T, Tong X, Zhang S, et al
Phase 2 Trial of Retatrutide for Obesity
Copper coordination gives the peptide a different analytical and biological context than the free GHK sequence, so appearance, complex notation, and purity matter more than the name alone
If loss stalls beyond 3 weeks, consult your PlexusDx provider about dose adjustment or metabolic testing, and consider the Precision Peptide Genetic Test to uncover pathway-specific barriers
This means less oxygen reaches the muscles and brain, causing fatigue and reduced concentration